Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V7QU
|
|||
| Drug Name |
Ureido-phenyl-substituted triazine derivative 2
|
|||
| Synonyms |
PMID28270010-Compound-Figure6-2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
ABRAXIS BIOSCIENCE, LLC
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H27N9OS2
|
|||
| Canonical SMILES |
CC1=CN=C(S1)NC2=NC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)NC4=CC=CC=C4)N5CCN(CC5)C
|
|||
| InChI |
1S/C25H27N9OS2/c1-17-16-26-24(36-17)30-21-29-22(34-14-12-33(2)13-15-34)32-25(31-21)37-20-10-8-19(9-11-20)28-23(35)27-18-6-4-3-5-7-18/h3-11,16H,12-15H2,1-2H3,(H2,27,28,35)(H,26,29,30,31,32)
|
|||
| InChIKey |
RZAWEAWFWJQMTD-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tropomyosin-related kinase A (TrkA) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Tropomyosin-related kinase A (TrkA) | Target's Patent Info | [1] | |
| KEGG Pathway | MAPK signaling pathway | |||
| Endocytosis | ||||
| Apoptosis | ||||
| Neurotrophin signaling pathway | ||||
| Inflammatory mediator regulation of TRP channels | ||||
| Pathways in cancer | ||||
| Transcriptional misregulation in cancer | ||||
| Thyroid cancer | ||||
| Central carbon metabolism in cancer | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | Neurotrophic factor-mediated Trk receptor signaling | |||
| Reactome | Frs2-mediated activation | |||
| ARMS-mediated activation | ||||
| NGF-independant TRKA activation | ||||
| PI3K/AKT activation | ||||
| WikiPathways | MAPK Signaling Pathway | |||
| BDNF signaling pathway | ||||
| Integrated Pancreatic Cancer Pathway | ||||
| NGF signalling via TRKA from the plasma membrane | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.Expert Opin Ther Pat. 2017 Jun;27(6):733-751. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.